Lts Lohmann Therapie-systeme Gmbh

Lts Lohmann Therapie-systeme Ag

Lts Lohmann Therapie-systeme Gmbh + Co. Kg

Hf Arzneimittelforschung Gmbh

Lts Lehman Therapie-systeme Gmbh

Frank Becher

Werner Wessling

Thomas Hille

Walter Muller

Thomas Kissel

Klaus Opitz

Joachim Moormann

Reinhard Koch

Ann-Katrin Klink

The invention relates to the use of galanthamine, as free base or as acid addition salt, for the treatment of cerebral, central nervous or psychiatric symptoms, defunctionalization manifestations or disorders occurring through intake of psychotropic substances as a consequence of occasional or chronic abuse of addictive substances, intoxicants or medicines, or as side effects of the use, especially repeated or prolonged, as intended of medicaments, or as an effect of use, in particular repeated or prolonged, not as intended of medicaments, or as a result of acute poisoning by psychotropic toxic substances, or as a result of chronic exposure to toxic substances with a psychotropic effect in humans or other vertebrates.

Use of galanthamine for the treatment of pathological manifestations of the central nervous system based on intoxications with psychotropic substances

Administration forms for application to the skin or mucosa, comprising a carrier matrix and at least one active substance, are characterized in that the carrier matrix has a plurality of particles having open pores or containing capillary spaces, said particles serving as active substance reservoir and containing at least one active substance.

Administration form with active substance-containing particles, for application on the skin or mucosa

A method for the protection of a human being against any health impairment as a result of the ingestion of the whole or parts of a transdermal therapeutic system containing at least one pharmacologically active ingredient, which is toxic or induces nausea or addiction at oral, but not at transdermal administration is disclosed. The method comprises adding to said transdermal therapeutic system a substance being able to keep off a human being from said ingestion.

Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system

A process for inscription of a sheet-like adhesive system of a polymer, preferably on the adhesive-free side thereof, with information is characterized in that the inscription is carried out with the aid of a movably guided laser beam in such a manner that a detrimental influence on the ingredients contained in the system, in particular by heat generated by the laser beam or by detrimental perforation of a backing layer impermeable to ingredients or water vapour, is avoided, and that to this end the intensity and penetration depth of the laser beam is adjusted according to the material properties of the system in such a way that the laser beam does not penetrate far enough to reach an ingredient-containing layer of the system.

Process and device for inscription of a sheet-like adhesive system of a polymer, especially of a transdermal therapeutic system

Methods for the treatment of patients are provided, such methods comprising applying to the patient a transdermal therapeutic system comprising a therapeutically effective substance such that the dosage of the therapeutically active substance remains constant over a prolonged period of time.

Method for transdermal application of active substances at high constant dosage

The invention concerns a transdermal application system for antithrombotic therapy and for the prophylaxis against cancer, respectively, containing as active substance acetylsalicylic acid and/or pharmaceutically acceptable salts thereof.

Transdermal application system containing acetylsalicylic acid for antithrombotic therapy and cancer prophylaxis

Volume-expandable, sheet-like application form suitable as an active

A method for the application of an active substance patch for controlling or alleviating an addiction such as drug addiction, addiction to pills or analgesia is characterized in that two or more active substance patches are applied simultaneously, sequentially or alternately within a given therapy plan under surveillance of the blood level of the active substance in a way that allows the achievement of an active substance blood level which is high enough for a successful suppression of the addiction and remains constantly effective throughout a useful period of administration.

Method for the application of an active substance patch for controlling

Childproof package for active substance patches

Process and a device for producing a transdermal therapeutic system for

The invention relates to a fixing system for fixing catheters, cannulas, etc. with a skin film (3) coated with a skin adhesion layer (2) and having a cover film (1) and an overplaster (6) finished with a pressure sensitive adhesive layer (5) adhering to the skin film and having an overplaster cover layer (4), as well as to a process for the sterile fastening of a cannula to the skin with the following steps: application of a bacteria-tight skin film with skin adhesion layer to the skin in the insertion region of the cannula, passing the cannula through the skin film, applying an adhesive forming an elastic, bacteria-tight film adhering to the skin film region surrounding the insertion point and the cannula portion projecting out of the skin and sticking the overplaster over the cannula.

Growing community of inventors

Koblenz, Germany

Frank Becher